Facebook
Twitter
Telegram
Report an ErrorKodiak Sciences Balance Sheet 2011-2024 | KOD
Annual Balance Sheet Kodiak Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-204 M | -103 M | -652 M | - | -210 M | -88.3 M | 8.69 M | -9.44 M | - | - | - | - | - |
Long Term Debt |
71.9 M | 77.8 M | 76.1 M | - | - | - | 9.92 M | - | - | - | - | - | - |
Long Term Debt Current |
9.77 M | 9.93 M | 3.93 M | 2.37 M | 434 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 1.8 M | 530 K | 62.8 M | 50.7 M | - | - | - | - | - |
Total Current Liabilities |
41.7 M | 52.5 M | 64.7 M | 31.4 M | 11.7 M | 4.83 M | - | - | - | - | - | - | - |
Total Liabilities |
214 M | 230 M | 241 M | 207 M | 13.5 M | 5.36 M | 72 M | 53.2 M | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.15 B | -892 M | -558 M | -291 M | -158 M | -111 M | -69.3 M | -41.4 M | - | - | - | - | - |
Total Assets |
479 M | 667 M | 904 M | 1.07 B | 359 M | 92.2 M | 3.24 M | 12.1 M | - | - | - | - | - |
Cash and Cash Equivalents |
286 M | 190 M | 732 M | 944 M | 212 M | 88.3 M | 1.4 M | - | - | - | - | - | - |
Book Value |
266 M | 436 M | 663 M | 861 M | 345 M | 86.8 M | -68.7 M | -41.1 M | - | - | - | - | - |
Total Shareholders Equity |
266 M | 436 M | 663 M | 861 M | 345 M | 86.8 M | -68.7 M | -41.1 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Kodiak Sciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
68.7 M | 71.9 M | 74.5 M | 76.9 M | 78.8 M | 77.8 M | 78.7 M | 81 M | 76.4 M | 76.1 M | 77.3 M | 77 M | 75.9 M | 75 M | 75 M | 75 M | 75 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
194 M | 214 M | 245 M | 251 M | 248 M | 230 M | 244 M | 251 M | 253 M | 241 M | 232 M | 218 M | 211 M | 207 M | 207 M | 207 M | 207 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 5.36 M | 5.36 M | 5.36 M | 5.36 M | 22 M | 22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.2 B | -1.15 B | -1.09 B | -1.04 B | -963 M | -892 M | -822 M | -745 M | -654 M | -558 M | -465 M | -398 M | -342 M | -291 M | -291 M | -291 M | -291 M | -158 M | -158 M | -158 M | -158 M | -111 M | -111 M | -111 M | -111 M | -69.3 M | -69.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
435 M | 479 M | 548 M | 590 M | 640 M | 667 M | 724 M | 782 M | 850 M | 904 M | 958 M | 998 M | 1.03 B | 1.07 B | 1.07 B | 1.07 B | 1.07 B | 359 M | 359 M | 359 M | 359 M | 92.2 M | 92.2 M | 92.2 M | 92.2 M | 3.24 M | 3.24 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
246 M | 286 M | 346 M | 379 M | 317 M | 190 M | 178 M | 173 M | 672 M | 732 M | 799 M | 881 M | 920 M | 944 M | 944 M | 944 M | 944 M | 212 M | 212 M | 212 M | 212 M | 88.3 M | 88.3 M | 88.3 M | 88.3 M | 1.4 M | 1.4 M | - | - | 9.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
241 M | 266 M | 302 M | 338 M | 393 M | 436 M | 480 M | 531 M | 597 M | 663 M | 726 M | 779 M | 822 M | 861 M | 861 M | 861 M | 861 M | 345 M | 345 M | 345 M | 345 M | 86.8 M | 86.8 M | 86.8 M | 86.8 M | -18.7 M | -18.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
241 M | 266 M | 302 M | 338 M | 393 M | 436 M | 480 M | 531 M | 597 M | 663 M | 726 M | 779 M | 822 M | 861 M | 861 M | 861 M | 861 M | 345 M | 345 M | 345 M | 345 M | 86.8 M | 86.8 M | 86.8 M | 86.8 M | -68.7 M | -68.7 M | - | - | -41.1 M | - | - | - | -24.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency